MYC and colorectal carcinoma: Recent findings indicate that PRMT6 facilitates CRC advancement by activating MYC signaling, whereas increased MYC activity and epithelial-mesenchymal transition (EMT) pathways may further intensify CRC malignancy (51, 52).